SCHEMBL1819656

SCHEMBL1819656

NC(c1cccc(C(F)(F)F)c1)C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.56
IDO1 P14902 3/20 0.53
TDO2 P48775 2/20 0.53
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
ACP3 P15309 2/20 0.47
CES2 O00748 2/20 0.47
OPRL1 P41146 3/20 0.46
OPRM1 P35372 2/20 0.46
OPRD1 P41143 2/20 0.46
OPRK1 P41145 2/20 0.46
TAAR1 Q96RJ0 1/20 0.43
DAO P14920 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4461161 0.98 IDO1 (0.56) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL12087043 0.86 PNMT (0.54) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL12656487 0.85 PNMT (0.53) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL7207335 0.83 PNMT (0.59) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL29897739 0.83 PNMT (0.59) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL24017114 0.83 PNMT (0.59) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL9679731 0.83 PNMT (0.59) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL15137235 0.83 PNMT (0.59) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL10958579 0.83 PNMT (0.51) PNMTIDO1TDO2TSHRMAPK1
SCHEMBL30117092 0.82 PNMT (0.54) PNMTIDO1TDO2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed
US-9491941-B2 (Hetero) arylacrylamides for the control of ectoparasites NOVARTIS TIERGESUNDHEIT AG (CH) 2016-11-15 US disclosed
US-20150320044-A1 (HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES ELANCO TIERGESUNDHEIT AG (CH) 2015-11-12 US disclosed
EP-2934133-A1 (HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES Novartis Tiergesundheit AG (CH) 2015-10-28 EP disclosed
US-9107411-B2 Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-08-18 US disclosed
EP-2885301-A1 AZAINDOLE CARBOXYLIC ACID AMIDES AND AZAINDOLE THIOCARBOXYLIC ACID AMIDES FOR USE AS INSECTICIDES AND ACARICIDES Bayer CropScience AG (DE) 2015-06-24 EP disclosed
EP-2683688-B1 INDOLECARBOXAMIDES AND BENZIMIDAZOLECARBOXAMIDES AS INSECTICIDES AND ACARICIDES BAYER IP GMBH (DE) 2015-05-06 EP disclosed
US-20150065343-A1 Acrylamide compounds for combating invertebrate pests BASF SE (DE) 2015-03-05 US disclosed
US-8889878-B2 Haloalky-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2014-11-18 US disclosed
US-8889878-B2 Haloalky-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2014-11-18 US disclosed
US-20130172390-A1 Haloalkyl-Substituted Amides as Insecticides and Acaricides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-07-04 US disclosed
US-20130172390-A1 Haloalkyl-Substituted Amides as Insecticides and Acaricides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-07-04 US disclosed
US-20130172390-A1 Haloalkyl-Substituted Amides as Insecticides and Acaricides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-07-04 US disclosed
WO-2012119984-A1 INDOLECARBOXAMIDES AND BENZIMIDAZOLECARBOXAMIDES AS INSECTICIDES AND ACARICIDES BAYER CROPSCIENCE AG (DE) 2012-09-13 WO disclosed
EP-2493844-A2 HALOGENALKYL-SUBSTITUTED AMIDES USED AS INSECTICIDES AND ACARICIDES Bayer CropScience AG (DE) 2012-09-05 EP disclosed
WO-2011054436-A2 HALOGENALKYL-SUBSTITUTED AMIDES USED AS INSECTICIDES AND ACARICIDES BAYER CROPSCIENCE AG (DE) 2011-05-12 WO disclosed
WO-2011054436-A2 HALOGENALKYL-SUBSTITUTED AMIDES USED AS INSECTICIDES AND ACARICIDES BAYER CROPSCIENCE AG (DE) 2011-05-12 WO disclosed
US-20110105532-A1 Haloalkyl-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2011-05-05 US disclosed
US-20110105532-A1 Haloalkyl-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2011-05-05 US disclosed
US-20110105532-A1 Haloalkyl-substituted amides as insecticides and acaricides BAYER CROPSCIENCE AG (DE) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320044-A1 (HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES AAAS, TYR, CAT PNMT 72/4885IDO1 79/4885TDO2 2305/4885
US-20130172390-A1 Haloalkyl-Substituted Amides as Insecticides and Acaricides CRYAA, ACLY, CRYZ PNMT 2799/4885IDO1 2510/4885TDO2 2221/4885
US-20150065343-A1 Acrylamide compounds for combating invertebrate pests AAAS, ACR, ATL3 PNMT 54/4885IDO1 1041/4885TDO2 2265/4885
US-20110105532-A1 Haloalkyl-substituted amides as insecticides and acaricides CRYAA, ACLY, CRYZ PNMT 2799/4885IDO1 2510/4885TDO2 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.